Clinical Trials Browser

Interventional × Bites and Stings × 1 year × Clear all

NCT04221542 2026-03-06

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Recruiting

Bites and Stings, Prostatic Neoplasms

NCT06063317 2026-03-06

OASIS

Phase 1 Terminated

Bites and Stings

NCT07280013 2026-03-05

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Phase 1 Recruiting

Bites and Stings, Multiple Myeloma, Recurrence

NCT05361395 2026-03-03

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Phase 1 Active not recruiting

Bites and Stings, Lung Neoplasms

NCT07388953 2026-02-13

BAPTAP

Phase NA Recruiting

Gastrointestinal

Agnosia, Bites and Stings, Pain, Postoperative, Colorectal Neoplasms

NCT03843359 2026-01-08

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

97 enrolled 45 charts

Bites and Stings, Neoplasms

NCT06022029 2025-12-24

ON-5001

Phase 1 Recruiting

BreastDermatologicGenitourinaryGynecologicHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

NCT03319940 2025-11-19

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

Phase 1 Active not recruiting

Bites and Stings, Neoplasms, Small Cell Lung Carcinoma

NCT06601296 2025-11-12

SPARK

Phase 2 Recruiting

Bites and Stings, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms

NCT04631601 2025-10-07

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 1/2 Terminated

Bites and Stings

NCT07078773 2025-08-13

Application of Pericapsular Nerve Group (PENG) Block

Phase NA Active not recruiting

Bites and Stings

NCT07106684 2025-08-06

CAREMM-004

Phase 2 Recruiting

Other hematologic neoplasmPlasma cell

Bites and Stings, Leukemia, Plasma Cell, Multiple Myeloma

NCT07106710 2025-08-06

CAREMM-005

Phase 2 Recruiting

Bites and Stings, Multiple Myeloma

NCT07106736 2025-08-06

MAGIC-TIEMM

Phase 2 Recruiting

Bites and Stings, Multiple Myeloma

NCT05992363 2025-07-24

TSTENT

Phase NA Recruiting

Bites and Stings, Hydronephrosis, Neoplasms, Ureteral Obstruction, Renal Insufficiency